Skip to content
Markets News
Stocks1 min read

Canopy Growth Slips as Major US Indexes Post Small Gains

Makkler Newsroom
October 1, 2026

The stock fell against market gains as Zacks' estimates point to higher quarterly sales and a projected full-year loss.

Canopy Growth shares fell 1.54% to $0.88 in the latest session, while the S&P 500 gained 0.2%. The Dow and Nasdaq each rose 0.04%.

Over the past month, the stock had lost 7.43%. That was a larger decline than the Medical sector’s 1.75% loss and the S&P 500’s 0.35% drop over the same period.

Ahead of the company’s upcoming earnings report, Zacks’ consensus estimate calls for a loss of $0.03 per share and revenue of $59.12 million. The earnings estimate is down 200% from the year-earlier quarter, while the revenue forecast is up 22.09%.

For the full fiscal year, Zacks estimates a loss of $0.10 per share and revenue of $243.53 million. It said those forecasts represent changes of 77.78% and 18.24%, respectively, from the prior year.

Zacks said analyst estimate revisions can reflect short-term business trends. Its consensus estimate for Canopy Growth’s earnings per share was unchanged over the past 30 days.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.